CHAPEL HILL, N.C., May 6, 2016 /PRNewswire/ -- Disease state
awareness campaigns are one of the few ways to inform patients and
physicians before a product is approved. In essence, they set the
table for future marketing efforts at product launch and
post-launch.
Disease awareness campaigns have long been used by the
pharmaceutical industry to disseminate unbranded information about
the characteristics of a particular disease, and how it affects
patients. But while some organizations are effectively utilizing
disease awareness programs, other companies are struggling to
connect their campaigns to their targeted audiences.
To help pharma leaders better understand how to effectively
utilize disease awareness programs to support pipeline portfolio
products, Best Practices, LLC has published a new research study
that delivers reliable industry metrics on current disease state
awareness program structure, spend, and activities.
"Disease Awareness Program Excellence: Structure, Activities
& Resources Needed for Effective Pipeline Support" identifies
what disease awareness activities and investment levels are most
effective for supporting pipeline products during both development
and post-marketing periods.
The study provides current insights on questions such as:
- When are companies first using disease awareness programs, and
when are they most effective in the product lifecycle?
- When should you invest the most resources in disease awareness
campaigns?
- Which disease awareness activities are best suited for social
media?
Pharmaceutical leaders will be able to use the research results
to see how their disease awareness programs stack up against
industry averages and trends.
Sixteen leaders at 16 leading pharmaceutical and biotech
organizations participated in this study. In addition, one global
communications firm representing a biopharma client also
participated. Four executives also took part in deep-dive
operational interviews.
To learn more about this report, download a complimentary report
excerpt at http://www.best-in-class.com/rr1427.htm.
For related research, visit our Best Practices, LLC website at
www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking and advisory
services firm serving pharmaceutical and medical device companies
worldwide. Best Practices, LLC's clients include all the top 10 and
most of the top 50 pharmaceutical companies. Best Practices, LLC
believes in the profound principle that organizations can chart a
course to superior economic performance by studying the best
business practices, operating tactics and winning strategies of
world-class companies.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/new-study-highlights-current-trends-in-how-the-pharmaceutical-industry-conducts-disease-state-awareness-campaigns-300264520.html
SOURCE Best Practices, LLC